284 related articles for article (PubMed ID: 26134901)
21. Insect cells as a factory to produce adeno-associated virus type 2 vectors.
Urabe M; Ding C; Kotin RM
Hum Gene Ther; 2002 Nov; 13(16):1935-43. PubMed ID: 12427305
[TBL] [Abstract][Full Text] [Related]
22. Achieving High-Yield Production of Functional AAV5 Gene Delivery Vectors via Fedbatch in an Insect Cell-One Baculovirus System.
Joshi PRH; Cervera L; Ahmed I; Kondratov O; Zolotukhin S; Schrag J; Chahal PS; Kamen AA
Mol Ther Methods Clin Dev; 2019 Jun; 13():279-289. PubMed ID: 30886878
[TBL] [Abstract][Full Text] [Related]
23. Intron splicing-mediated expression of AAV Rep and Cap genes and production of AAV vectors in insect cells.
Chen H
Mol Ther; 2008 May; 16(5):924-30. PubMed ID: 18388928
[TBL] [Abstract][Full Text] [Related]
24. Successful production of pseudotyped rAAV vectors using a modified baculovirus expression system.
Kohlbrenner E; Aslanidi G; Nash K; Shklyaev S; Campbell-Thompson M; Byrne BJ; Snyder RO; Muzyczka N; Warrington KH; Zolotukhin S
Mol Ther; 2005 Dec; 12(6):1217-25. PubMed ID: 16213797
[TBL] [Abstract][Full Text] [Related]
25. Replication of rep-cap genes is essential for the high-efficiency production of recombinant AAV.
Fan PD; Dong JY
Hum Gene Ther; 1997 Jan; 8(1):87-98. PubMed ID: 8989998
[TBL] [Abstract][Full Text] [Related]
26. Genetic Modification of the AAV5 Capsid with Lysine Residues Results in a Lung-Tropic Liver-Detargeted Gene Transfer Vector.
Stiles KM; Frenk EZ; Kaminsky SM; Crystal RG
Hum Gene Ther; 2022 Feb; 33(3-4):148-154. PubMed ID: 35018834
[TBL] [Abstract][Full Text] [Related]
27. Efficient recombinant adeno-associated virus production by a stable rep-cap HeLa cell line correlates with adenovirus-induced amplification of the integrated rep-cap genome.
Chadeuf G; Favre D; Tessier J; Provost N; Nony P; Kleinschmidt J; Moullier P; Salvetti A
J Gene Med; 2000; 2(4):260-8. PubMed ID: 10953917
[TBL] [Abstract][Full Text] [Related]
28. Adeno-associated virus type 2 VP2 capsid protein is nonessential and can tolerate large peptide insertions at its N terminus.
Warrington KH; Gorbatyuk OS; Harrison JK; Opie SR; Zolotukhin S; Muzyczka N
J Virol; 2004 Jun; 78(12):6595-609. PubMed ID: 15163751
[TBL] [Abstract][Full Text] [Related]
29. Serotype-specific replicating AAV helper constructs increase recombinant AAV type 2 vector production.
Li C; Samulski RJ
Virology; 2005 Apr; 335(1):10-21. PubMed ID: 15823602
[TBL] [Abstract][Full Text] [Related]
30. A novel method using baculovirus-mediated gene transfer for production of recombinant adeno-associated virus vectors.
Sollerbrant K; Elmén J; Wahlestedt C; Acker J; Leblois-Prehaud H; Latta-Mahieu M; Yeh P; Perricaudet M
J Gen Virol; 2001 Sep; 82(Pt 9):2051-2060. PubMed ID: 11514714
[TBL] [Abstract][Full Text] [Related]
31. Rapid, simple, and versatile manufacturing of recombinant adeno-associated viral vectors at scale.
Lock M; Alvira M; Vandenberghe LH; Samanta A; Toelen J; Debyser Z; Wilson JM
Hum Gene Ther; 2010 Oct; 21(10):1259-71. PubMed ID: 20497038
[TBL] [Abstract][Full Text] [Related]
32. High-Level rAAV Vector Production by rAdV-Mediated Amplification of Small Amounts of Input Vector.
Weger S
Viruses; 2022 Dec; 15(1):. PubMed ID: 36680104
[TBL] [Abstract][Full Text] [Related]
33. [Capsid assembly and DNA encapsidation of adeno-associated virus].
Wang Q; Lü Y; Li Z; Diao Y; Xu R
Sheng Wu Gong Cheng Xue Bao; 2011 Apr; 27(4):531-8. PubMed ID: 21847986
[TBL] [Abstract][Full Text] [Related]
34. Factors influencing recombinant adeno-associated virus production.
Salvetti A; Orève S; Chadeuf G; Favre D; Cherel Y; Champion-Arnaud P; David-Ameline J; Moullier P
Hum Gene Ther; 1998 Mar; 9(5):695-706. PubMed ID: 9551617
[TBL] [Abstract][Full Text] [Related]
35. Significant Differences in Capsid Properties and Potency Between Adeno-Associated Virus Vectors Produced in Sf9 and HEK293 Cells.
Giles A; Lock M; Chen SJ; Turner K; Wesolowski G; Prongay A; Petkov BN; Olagbegi K; Yan H; Wilson JM
Hum Gene Ther; 2023 Oct; 34(19-20):1003-1021. PubMed ID: 37597192
[TBL] [Abstract][Full Text] [Related]
36. Latest developments in the large-scale production of adeno-associated virus vectors in insect cells toward the treatment of neuromuscular diseases.
Galibert L; Merten OW
J Invertebr Pathol; 2011 Jul; 107 Suppl():S80-93. PubMed ID: 21784234
[TBL] [Abstract][Full Text] [Related]
37. Evidence for encapsidation of prokaryotic sequences during recombinant adeno-associated virus production and their in vivo persistence after vector delivery.
Chadeuf G; Ciron C; Moullier P; Salvetti A
Mol Ther; 2005 Oct; 12(4):744-53. PubMed ID: 16023415
[TBL] [Abstract][Full Text] [Related]
38. A Lac Repressor-Inducible Baculovirus Expression Vector for Controlling Adeno-Associated Virus Capsid Ratios.
Slack J; Nguyen C; Ibe-Enwo A
Viruses; 2023 Dec; 16(1):. PubMed ID: 38257750
[TBL] [Abstract][Full Text] [Related]
39. Systematic comparison of rAAV vectors manufactured using large-scale suspension cultures of Sf9 and HEK293 cells.
Liu S; Li J; Peraramelli S; Luo N; Chen A; Dai M; Liu F; Yu Y; Leib RD; Li Y; Lin K; Huynh D; Li S; Ou L
Mol Ther; 2024 Jan; 32(1):74-83. PubMed ID: 37990495
[TBL] [Abstract][Full Text] [Related]
40. Production of recombinant adeno-associated type 5 (rAAV5) vectors using recombinant herpes simplex viruses containing rep and cap.
Wustner JT; Arnold S; Lock M; Richardson JC; Himes VB; Kurtzman G; Peluso RW
Mol Ther; 2002 Oct; 6(4):510-8. PubMed ID: 12377193
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
